{"id":"https://openalex.org/W4284880971","doi":"https://doi.org/10.1007/s00280-022-04442-2","title":"A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan","display_name":"A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan","alternate_titles":[],"publication_year":2022,"publication_date":"2022-07-01","ids":{"openalex":"https://openalex.org/W4284880971","doi":"https://doi.org/10.1007/s00280-022-04442-2","pmid":"https://pubmed.ncbi.nlm.nih.gov/35796785","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9300521"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-022-04442-2","doi":"https://doi.org/10.1007/s00280-022-04442-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-022-04442-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-022-04442-2.pdf","source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4284880971"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00280-022-04442-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056287200","display_name":"Kenichi Ishizawa","orcid":"https://orcid.org/0000-0003-4911-8889","observed_orcids":["https://orcid.org/0000-0003-4911-8889","https://orcid.org/0009-0004-5182-4832"]},"institutions":[{"id":"https://openalex.org/I4210165438","display_name":"Yamagata University Hospital","ror":"https://ror.org/05gg4qm19","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210165438"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kenichi Ishizawa","raw_affiliation_strings":["Department of Hematology, Yamagata University Hospital, Yamagata, Japan. kishizaw@med.id.yamagata-u.ac.jp","Department of Hematology, Yamagata University Hospital, Yamagata, Japan"],"raw_orcid":"https://orcid.org/0000-0003-4911-8889","affiliations":[{"raw_affiliation_string":"Department of Hematology, Yamagata University Hospital, Yamagata, Japan. kishizaw@med.id.yamagata-u.ac.jp","institution_ids":["https://openalex.org/I4210165438"]},{"raw_affiliation_string":"Department of Hematology, Yamagata University Hospital, Yamagata, Japan","institution_ids":["https://openalex.org/I4210165438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109272656","display_name":"Masahiro Yokoyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Yokoyama","raw_affiliation_strings":["Department of Hematology Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103224600","display_name":"Harumi Kato","orcid":"https://orcid.org/0000-0003-3215-236X","observed_orcids":["https://orcid.org/0000-0003-3215-236X"]},"institutions":[{"id":"https://openalex.org/I4210133851","display_name":"Aichi Cancer Center","ror":"https://ror.org/03kfmm080","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Harumi Kato","raw_affiliation_strings":["Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan","institution_ids":["https://openalex.org/I4210133851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018968800","display_name":"Kazuhito Yamamoto","orcid":"https://orcid.org/0000-0002-8588-8955","observed_orcids":["https://orcid.org/0000-0002-8588-8955"]},"institutions":[{"id":"https://openalex.org/I4210133851","display_name":"Aichi Cancer Center","ror":"https://ror.org/03kfmm080","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhito Yamamoto","raw_affiliation_strings":["Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan","institution_ids":["https://openalex.org/I4210133851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049002681","display_name":"Masanori Makita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152032","display_name":"Okayama Medical Center","ror":"https://ror.org/041c01c38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4210152032"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masanori Makita","raw_affiliation_strings":["Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan","institution_ids":["https://openalex.org/I4210152032"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103757378","display_name":"Kiyoshi Ando","orcid":"https://orcid.org/0000-0002-5153-8850","observed_orcids":["https://orcid.org/0000-0002-5153-8850"]},"institutions":[{"id":"https://openalex.org/I4210115139","display_name":"Tokai University Hospital","ror":"https://ror.org/01gvmn480","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210115139"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyoshi Ando","raw_affiliation_strings":["Department of Hematology and Oncology, Tokai University Hospital, Isehara, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Tokai University Hospital, Isehara, Japan","institution_ids":["https://openalex.org/I4210115139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103131907","display_name":"Yasunori Ueda","orcid":"https://orcid.org/0000-0002-4487-5808","observed_orcids":["https://orcid.org/0000-0002-4487-5808"]},"institutions":[{"id":"https://openalex.org/I4210089671","display_name":"Kurashiki Central Hospital","ror":"https://ror.org/00947s692","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210089671"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasunori Ueda","raw_affiliation_strings":["Department of Hematology/Oncology, Ohara HealthCare Foundation Kurashiki Central Hospital, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology, Ohara HealthCare Foundation Kurashiki Central Hospital, Kurashiki, Japan","institution_ids":["https://openalex.org/I4210089671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113760437","display_name":"Yoshimichi Tachikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093709","display_name":"National Hospital Organization Kyushu Cancer Center","ror":"https://ror.org/00mce9b34","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210093709","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshimichi Tachikawa","raw_affiliation_strings":["Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan","institution_ids":["https://openalex.org/I4210093709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112363403","display_name":"Youko Suehiro","orcid":"https://orcid.org/0009-0003-5690-4228","observed_orcids":["https://orcid.org/0009-0003-5690-4228"]},"institutions":[{"id":"https://openalex.org/I4210093709","display_name":"National Hospital Organization Kyushu Cancer Center","ror":"https://ror.org/00mce9b34","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210093709","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Youko Suehiro","raw_affiliation_strings":["Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan","institution_ids":["https://openalex.org/I4210093709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035118858","display_name":"Mitsutoshi Kurosawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164631","display_name":"Sapporo National Hospital","ror":"https://ror.org/05afnhv08","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4210164631"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsutoshi Kurosawa","raw_affiliation_strings":["Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan","institution_ids":["https://openalex.org/I4210164631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060770246","display_name":"Yoshihiro Kameoka","orcid":"https://orcid.org/0000-0002-6786-3439","observed_orcids":["https://orcid.org/0000-0002-6786-3439"]},"institutions":[{"id":"https://openalex.org/I4210132405","display_name":"Akita University Hospital","ror":"https://ror.org/02szmmq82","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132405"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiro Kameoka","raw_affiliation_strings":["Department of Hematology, Akita University Hospital, Akita, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Akita University Hospital, Akita, Japan","institution_ids":["https://openalex.org/I4210132405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100861716","display_name":"Hirokazu Nagai","orcid":"https://orcid.org/0009-0005-6438-7931","observed_orcids":["https://orcid.org/0009-0005-6438-7931"]},"institutions":[{"id":"https://openalex.org/I4210152596","display_name":"Nagoya Medical Center","ror":"https://ror.org/04ftw3n55","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4210152596"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirokazu Nagai","raw_affiliation_strings":["Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan","institution_ids":["https://openalex.org/I4210152596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016541702","display_name":"Nobuhiko Uoshima","orcid":"https://orcid.org/0009-0005-1635-2785","observed_orcids":["https://orcid.org/0009-0005-1635-2785"]},"institutions":[{"id":"https://openalex.org/I4210151725","display_name":"Japanese Red Cross Society Kyoto Daini Hospital","ror":"https://ror.org/04xesg978","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151725"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuhiko Uoshima","raw_affiliation_strings":["Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan","institution_ids":["https://openalex.org/I4210151725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017171769","display_name":"Takayuki Ishikawa","orcid":"https://orcid.org/0000-0002-2098-9616","observed_orcids":["https://orcid.org/0000-0002-2098-9616"]},"institutions":[{"id":"https://openalex.org/I4210161700","display_name":"Kobe City Medical Center General Hospital","ror":"https://ror.org/04j4nak57","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210161700","https://openalex.org/I4405284131"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takayuki Ishikawa","raw_affiliation_strings":["Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan","institution_ids":["https://openalex.org/I4210161700"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101780242","display_name":"Michihiro Hidaka","orcid":"https://orcid.org/0000-0002-8645-2184","observed_orcids":["https://orcid.org/0000-0002-8645-2184"]},"institutions":[{"id":"https://openalex.org/I4210165499","display_name":"Kumamoto Medical Center","ror":"https://ror.org/05sy5w128","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4210165499"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michihiro Hidaka","raw_affiliation_strings":["Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan","institution_ids":["https://openalex.org/I4210165499"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109514611","display_name":"Yoshikiyo Ito","orcid":"https://orcid.org/0000-0003-0331-4630","observed_orcids":["https://orcid.org/0000-0003-0331-4630"]},"institutions":[{"id":"https://openalex.org/I4210125681","display_name":"Imamura Hospital","ror":"https://ror.org/02xt2gf57","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210125681"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshikiyo Ito","raw_affiliation_strings":["Department of Hematology, Imamura General Hospital, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Imamura General Hospital, Kagoshima, Japan","institution_ids":["https://openalex.org/I4210125681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038965321","display_name":"Atae Utsunomiya","orcid":"https://orcid.org/0000-0002-8843-406X","observed_orcids":["https://orcid.org/0000-0002-8843-406X"]},"institutions":[{"id":"https://openalex.org/I4210125681","display_name":"Imamura Hospital","ror":"https://ror.org/02xt2gf57","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210125681"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atae Utsunomiya","raw_affiliation_strings":["Department of Hematology, Imamura General Hospital, Kagoshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Imamura General Hospital, Kagoshima, Japan","institution_ids":["https://openalex.org/I4210125681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069236780","display_name":"Koji Fukushima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267378","display_name":"SymBio Pharmaceuticals Limited (Japan)","ror":"https://ror.org/02g42wq61","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405267378"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koji Fukushima","raw_affiliation_strings":["SymBio Pharmaceuticals Limited, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SymBio Pharmaceuticals Limited, Tokyo, Japan","institution_ids":["https://openalex.org/I4405267378"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015509689","display_name":"Michinori Ogura","orcid":"https://orcid.org/0000-0002-6853-4688","observed_orcids":["https://orcid.org/0000-0002-6853-4688"]},"institutions":[{"id":"https://openalex.org/I4210103227","display_name":"Kasugai Municipal Hospital","ror":"https://ror.org/019ekef14","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210103227"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michinori Ogura","raw_affiliation_strings":["Department of Hematology and Oncology, Kasugai Municipal Hospital, Kasugai, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Kasugai Municipal Hospital, Kasugai, Japan","institution_ids":["https://openalex.org/I4210103227"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":17,"corresponding_author_ids":["https://openalex.org/A5056287200"],"corresponding_institution_ids":["https://openalex.org/I4210165438"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":0.3998,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.55772277,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"90","issue":"1","first_page":"83","last_page":"95"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bendamustine-hydrochloride","display_name":"bendamustine hydrochloride","score":0.9359999895095825},{"id":"https://openalex.org/keywords/rapid-infusion","display_name":"rapid infusion","score":0.703000009059906},{"id":"https://openalex.org/keywords/indolent-b-cell-non-hodgkin-lymphoma","display_name":"indolent B-cell non-Hodgkin lymphoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9070000052452087},{"id":"https://openalex.org/keywords/relapsed-refractory-diffuse-large-b-cell-lymphoma","display_name":"relapsed/refractory diffuse large B-cell lymphoma","score":0.9800000190734863},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8569999933242798},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7739999890327454},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8989999890327454},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9079999923706055},{"id":"https://openalex.org/keywords/lymphocyte-count-reduction","display_name":"lymphocyte count reduction","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.9182468056678772},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8518832921981812},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.789334774017334},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6121813058853149},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5731719732284546},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.5265890955924988},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5240426659584045},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5094752907752991},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4827927350997925},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.47636887431144714},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4607769846916199},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4227087199687958},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4173106849193573},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.29176419973373413},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069461","descriptor_name":"Bendamustine Hydrochloride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069461","descriptor_name":"Bendamustine Hydrochloride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D020522","descriptor_name":"Lymphoma, Mantle-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1007/s00280-022-04442-2","doi":"https://doi.org/10.1007/s00280-022-04442-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-022-04442-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-022-04442-2.pdf","source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:35796785","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35796785","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:9300521","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9300521/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemother Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s00280-022-04442-2","doi":"https://doi.org/10.1007/s00280-022-04442-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00280-022-04442-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00280-022-04442-2.pdf","source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F2247101519","display_name":"Scientific and Research Department, Plovdiv University 'Paisii Hilendarski'","ror":null},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307112","display_name":"Micron Technology","ror":"https://ror.org/02fv52296"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307771","display_name":"Bayer","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"},{"id":"https://openalex.org/F4320310465","display_name":"Takeda Pharmaceutical Company","ror":"https://ror.org/04hjbmv12"},{"id":"https://openalex.org/F4320312327","display_name":"Celltrion Healthcare","ror":null},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"},{"id":"https://openalex.org/F4320317858","display_name":"Nippon Shinyaku","ror":"https://ror.org/05wyn3p10"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320321627","display_name":"Dainippon Sumitomo Pharma","ror":"https://ror.org/04sapgw72"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320322359","display_name":"Kyowa Hakko Kirin","ror":"https://ror.org/0586k5242"},{"id":"https://openalex.org/F4320322415","display_name":"Meiji Seika Pharma","ror":"https://ror.org/027tjex48"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"},{"id":"https://openalex.org/F4320326474","display_name":"Teijin Pharma","ror":"https://ror.org/001144c36"},{"id":"https://openalex.org/F4320327436","display_name":"Yakult Honsha","ror":"https://ror.org/03wmnrc91"},{"id":"https://openalex.org/F4320327845","display_name":"Ono Pharmaceutical","ror":"https://ror.org/022jefx64"},{"id":"https://openalex.org/F4320327847","display_name":"SymBio Pharmaceuticals Limited","ror":"https://ror.org/02g42wq61"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"},{"id":"https://openalex.org/F4320333376","display_name":"MSD K.K.","ror":"https://ror.org/01kaqxm37"},{"id":"https://openalex.org/F4320337449","display_name":"Janssen Biotech","ror":"https://ror.org/03qd7mz70"},{"id":"https://openalex.org/F6587916342","display_name":"Genmab","ror":null},{"id":"https://openalex.org/F7525850861","display_name":"JIMRO","ror":null},{"id":"https://openalex.org/F8959412486","display_name":"Mundipharma","ror":"https://ror.org/031y8s059"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4284880971.pdf","grobid_xml":"https://content.openalex.org/works/W4284880971.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W67299084","https://openalex.org/W1945274657","https://openalex.org/W1965943183","https://openalex.org/W1980372372","https://openalex.org/W1986250794","https://openalex.org/W1986522232","https://openalex.org/W2006546916","https://openalex.org/W2008108259","https://openalex.org/W2017744478","https://openalex.org/W2037252592","https://openalex.org/W2038989389","https://openalex.org/W2049660830","https://openalex.org/W2076668534","https://openalex.org/W2078603533","https://openalex.org/W2133201432","https://openalex.org/W2136326451","https://openalex.org/W2142019712","https://openalex.org/W2169209759","https://openalex.org/W2559707087","https://openalex.org/W2618671248","https://openalex.org/W3162595824","https://openalex.org/W4313146863"],"related_works":["https://openalex.org/W2049660830","https://openalex.org/W2083329993","https://openalex.org/W2586530523","https://openalex.org/W2559707087","https://openalex.org/W1909936798","https://openalex.org/W2470166535","https://openalex.org/W2081040247","https://openalex.org/W4312064887","https://openalex.org/W3190829031","https://openalex.org/W2272854720"],"abstract_inverted_index":{"Abstract":[0],"Purpose":[1],"This":[2,222],"phase":[3],"I/II":[4],"clinical":[5],"study":[6,223],"was":[7,54,81,94,106,134],"conducted":[8],"to":[9,60,71,83,96,109,211,245],"examine":[10],"the":[11,84,97],"safety,":[12],"tolerability,":[13],"pharmacokinetics,":[14],"and":[15,39,67,89,102,120,125,187,198,206,230],"efficacy":[16],"of":[17,20,168,208,249],"10-min":[18],"dosing":[19],"bendamustine":[21,91,209,226],"in":[22,122,136,155,159,166,171,214,218],"patients":[23,40,63,74,145,158,170,233],"with":[24,41,234],"previously":[25,235],"untreated":[26,236],"indolent":[27],"B-cell":[28,45],"non-Hodgkin":[29],"lymphoma":[30,35,46],"(iNHL)":[31],"or":[32,239],"mantle":[33],"cell":[34],"(MCL)":[36],"(Group":[37,48],"1)":[38],"relapsed/refractory":[42],"diffuse":[43],"large":[44],"(rrDLBCL)":[47],"2).":[49],"Methods":[50],"Rituximab":[51],"375":[52],"mg/m2":[53],"administered":[55,82,95],"intravenously":[56],"every":[57,68],"28":[58],"days":[59,70,87,100],"Group":[61,72,139,160,172,183,215,219],"1":[62,66,88,124,140],"on":[64,75,86,99],"day":[65,76],"21":[69],"2":[73,101,216],"1.":[77,161,220],"Bendamustine":[78],"90":[79],"mg/m2/day":[80,93],"former":[85],"2;":[90],"120":[92],"latter":[98],"3.":[103],"Each":[104],"regimen":[105],"delivered":[107],"up":[108],"six":[110,169],"cycles":[111],"for":[112,232],"both":[113],"groups.":[114],"The":[115,204],"primary":[116],"endpoints":[117],"were":[118,153,164,191,243],"safety":[119,133],"tolerability":[121],"Groups":[123],"2,":[126],"respectively.":[127,203],"Results":[128],"Among":[129],"37":[130],"enrolled":[131],"patients,":[132],"assessed":[135],"36.":[137],"In":[138,182],"(n":[141],"=":[142],"30),":[143],"27":[144],"(90%)":[146],"had":[147],"follicular":[148],"lymphoma.":[149],"Adverse":[150],"events":[151],"(AEs)":[152],"observed":[154,165],"all":[156],"30":[157],"Dose-limiting":[162],"toxicities":[163],"two":[167],"2.":[173],"Common":[174],"AEs":[175],"included":[176],"lymphocyte":[177],"count":[178],"decreased":[179],"(86.7%,":[180],"100%).":[181],"1,":[184],"overall":[185],"response":[186,189],"complete":[188],"rates":[190],"93.1%":[192],"(95%":[193,200],"confidence":[194],"interval":[195],"[CI]":[196],"77.2\u201399.2%)":[197],"75.9%":[199],"CI":[201],"56.5\u201389.7%),":[202],"Cmax":[205],"AUC":[207],"tended":[210],"be":[212],"higher":[213],"than":[217],"Conclusions":[221],"showed":[224],"that":[225],"is":[227],"safe,":[228],"well-tolerated":[229],"effective":[231],"iNHL,":[237],"MCL":[238],"rrDLBCL.":[240],"Pharmacokinetic":[241],"data":[242],"equivalent":[244],"those":[246],"obtained":[247],"outside":[248],"Japan.":[250],"Registration":[251,253],"numbers":[252],"NCT03900377;":[254],"registered":[255],"April":[256],"3,":[257],"2019.":[258]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4284880971","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-07-09T00:00:00"}
